Pivot Pharmaceuticals Inc. has signed a manufacture and supply agreement with F&B Cosmetics for skincare. The latter will be manufacturing the various products of Pivot’s CBD portfolio in the United States.
With its patented technologies, Pivot is expected to enter the American market in the first quarter of 2020. In conjunction with Joseph Mimran & Associates, Pivot is working to create a strong brand for its products in North America.
The goal of Pivot is to become the leading player in the CBD wellness medical market.
The CEO of Pivot, Dr. Rinow, said that their success was dependent on the effective launch of their products and the acclamation of its superiority by the customers. He explained that their focus is on value-added CBD and nutraceutical products and the obligation of delivering quality branded products. He concluded that their quality products and branding, they are in the perfect position to dominate the markets in the US, Europe, and Canada.